|Slideshows|May 25, 2017

4 Myths About Assisted Outpatient Treatment

Author(s)E. Fuller Torrey, MD, John D. Snook, JD

After lounging on the doorstep of respectability for the past decade, assisted outpatient treatment is here to stay. But some still balk at the notion.

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

4 Myths About Assisted Outpatient Treatment

Related Content

Anosognosia and the Criminalization of Schizophrenia: Implications for Clinical Practice

The Psychiatrist’s Preview of Legal Cases Against Big AI

Hotel Homicide, Hotel Suicide, and "The White Lotus"

Mandatory Reporting: Child Sexual Exploitation Material

Strategies for Improved Collaborative Management of Personality Disorders in Correctional Facilities

Latest CME

Southern California Psychiatry Conference

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Monoamines: A Full House

Dose Lithium Once a Day at Night: An Update

Understanding the Complexities of Suicide Risk: A Conversation With Jill Harkavy-Friedman, PhD, and Elizabeth Ballard, PhD

Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD

Consensus on Overcoming Barriers to Long-Acting Injectable Use in Schizophrenia